Compounds of formula IIA and IIB are novel guanidine compounds
##STR1##
where the variables R1 through R10 have the values set
forth herein. Such compounds have use in treating diseases such as obesity and
type II diabetes, and may be provided as pharmaceutical formulations in conjunction
with a pharmaceutically acceptable carrier.